Initial Management of Patients with Acute Heart Failure

Heart Failure Clinics

Volumn 9, Issue 3, 2013, Pages 291-301

  Fermann, Gregory J ^a   Collins, Sean P ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

Acute heart failure; Diagnosis; Emergency care; Risk stratification; Treatment

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CREATININE; DIURETIC AGENT; ENALAPRILAT; FUROSEMIDE; GLYCERYL TRINITRATE; MORPHINE; NESIRITIDE; NITROPRUSSIDE SODIUM; RELAXIN; TROPONIN; VASODILATOR AGENT;

ACUTE CORONARY SYNDROME; ACUTE HEART FAILURE; BLOOD PRESSURE REGULATION; CARDIOGENIC SHOCK; CARDIOMEGALY; CLINICAL DECISION MAKING; CREATININE BLOOD LEVEL; DIASTOLIC DYSFUNCTION; DISEASE DURATION; DIURETIC THERAPY; DRUG MEGADOSE; DYSPNEA; ELECTROCARDIOGRAPHY; FATIGUE; HEART AFTERLOAD; HEART ARRHYTHMIA; HEART EJECTION FRACTION; HEART MUSCLE NECROSIS; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; LEG EDEMA; LOW DRUG DOSE; META ANALYSIS (TOPIC); OUTPATIENT CARE; OXYGEN THERAPY; PERIPHERAL EDEMA; PHYSICAL EXAMINATION; PLEURA EFFUSION; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; SYMPTOM ASSESSMENT; THORAX RADIOGRAPHY; VITAL SIGN;

ACUTE DISEASE; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; DISEASE MANAGEMENT; HEART FAILURE; HUMANS;

EID: 84879786704     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2013.04.004     Document Type: Review

References (71)

1. Ahmed A., Allman R.M., Fonarow G.C., et al. Incident heart failure hospitalization and subsequent mortality in chronic heart failure: a propensity-matched study. JCard Fail 2008, 14:211.
2. Roger V.L., Go A.S., Lloyd-Jones D.M., et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012, 125(1):e2-e220.
3. Abraham W.T., Fonarow G.C., Albert N.M., et al. Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). JAm Coll Cardiol 2008, 52:347.
4. Fonarow G.C., Abraham W.T., Albert N.M., et al. Association between performance measures and clinical outcomes for patients hospitalized with heart failure. JAMA 2007, 297(1):61-70.
5. Fonarow G.C., Abraham W.T., Albert N.M., et al. Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF. Arch Intern Med 2008, 168:847.
6. O'Connor C.M., Abraham W.T., Albert N.M., et al. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). Am Heart J 2008, 156:662.
7. Fonarow G.C. Epidemiology and risk stratification in acute heart failure. Am Heart J 2008, 155:200.
8. Fermann G.J., Collins S.P. Observation units in the management of acute heart failure syndromes. Curr Heart Fail Rep 2010, 7(3):125-133.
9. Collins S.P., Schauer D.P., Gupta A., et al. Cost-effectiveness analysis of ED decision making in patients with non-high-risk heart failure. Am J Emerg Med 2009, 27(3):293.
10. Lee D.S., Schull M.J., Alter D.A., et al. Early deaths in patients with heart failure discharged from the emergency department: a population-based analysis. Circ Heart Fail 2010, 3(2):228-235.
11. Rame J.E., Sheffield M.A., Dries D.L., et al. Outcomes after emergency department discharge with a primary diagnosis of heart failure. Am Heart J 2001, 142(4):714-719.
12. Fonarow G.C., Abraham W.T., Albert N.M., et al. Day ofadmission and clinical outcomes for patients hospitalized for heart failure: findings from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF). Circ Heart Fail 2008, 1(1):50-57.
13. Collins S.P., Lindsell C.J., Jenkins C.A., et al. Risk stratification in acute heart failure: rationale and design of the STRATIFY and DECIDE studies. Am Heart J 2012, 164(6):825-834.
14. Collins S.P., Lindsell C.J., Pang P.S., et al. Bayesian adaptive trial design in acute heart failure syndromes: moving beyond the mega trial. Am Heart J 2012, 164(2):138-145.
15. Pang P.S., Jesse R., Collins S.P., et al. Patients with acute heart failure in the emergency department: do they all need to be admitted?. JCard Fail 2012, 18(12):900-903.
16. Stiell I.G., Clement C.M., Brison R.J., et al. Arisk scoring system to identify emergency department patients with heart failure at high risk for serious adverse events. Acad Emerg Med 2013, 20(1):17-26.
17. Wang C.S., FitzGerald J.M., Schulzer M., et al. Does this dyspneic patient in the emergency department have congestive heart failure?. JAMA 2005, 294(15):1944-1956.
18. Weintraub N.L., Collins S.P., Pang P.S., et al. Acute heart failure syndromes: emergency department presentation, treatment, and disposition: current approaches and future aims: a scientific statement from the American Heart Association. Circulation 2010, 122(19):1975-1996.
19. Slama M., Susic D., Varagic J., et al. Diastolic dysfunction in hypertension. Curr Opin Cardiol 2002, 17(4):368-373.
20. Chatterjee K., Massie B. Systolic and diastolic heart failure: differences and similarities. JCard Fail 2007, 13(7):569-576.
21. Collins S., Storrow A.B., Kirk J.D., et al. Beyond pulmonary edema: diagnostic, risk stratification, and treatment challenges of acute heart failure management in the emergency department. Ann Emerg Med 2008, 51(1):45-57.
22. Maisel A.S., Krishnaswamy P., Nowak R.M., et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. NEngl J Med 2002, 347(3):161-167.
23. McCullough P.A., Nowak R.M., McCord J., et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation 2002, 106(4):416-422.
24. Januzzi J.L., Camargo C.A., Anwaruddin S., et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 2005, 95(8):948-954.
25. Lamb E.J., Vickery S., Price C.P. Amino-terminal pro-brain natriuretic peptide to diagnose congestive heart failure in patients with impaired kidney function. JAm Coll Cardiol 2006, 48(5):1060-1061. [author reply: 1061].
26. Peacock W.F., De Marco T., Fonarow G.C., et al. Cardiac troponin and outcome in acute heart failure. NEngl J Med 2008, 358:2117.
27. Perna E.R., Aspromonte N., Cimbaro Canella J.P., et al. Minor myocardial damage is a prevalent condition in patients with acute heart failure syndromes and preserved systolic function with long-term prognostic implications: a report from the CIAST-HF (Collaborative Italo-Argentinean Study on Cardiac Troponin T in Heart Failure) study. JCard Fail 2012, 18(11):822-830.
28. Ahmadpour H., Shah A.A., Allen J.W., et al. Mitral E point septal separation: a reliable index of left ventricular performance in coronary artery disease. Am Heart J 1983, 106(1 Pt 1):21-28.
29. Secko M.A., Lazar J.M., Salciccioli L.A., et al. Can junior emergency physicians use E-point septal separation to accurately estimate left ventricular function in acutely dyspneic patients?. Acad Emerg Med 2011, 18(11):1223-1226.
30. Ramasubbu K., Deswal A., Chan W., et al. Echocardiographic changes during treatment of acute decompensated heart failure: insights from the ESCAPE trial. JCard Fail 2012, 18(10):792-798.
31. Channer K.S., Culling W., Wilde P., et al. Estimationof left ventricular end-diastolic pressure by pulsed Doppler ultrasound. Lancet 1986, 1(8488):1005-1007.
32. Picano E., Frassi F., Agricola E., et al. Ultrasound lung comets: a clinically useful sign of extravascular lung water. JAm Soc Echocardiogr 2006, 19(3):356-363.
33. Prosen G., Klemen P., Strnad M. Combination of lung ultrasound (a comet-tail sign) and N-terminal pro-brain natriuretic peptide in differentiating acute heart failure from chronic obstructive pulmonary disease and asthma as cause of acute dyspnea in prehospital emergency setting. Crit Care 2011, 15(2):R114.
34. Felker G.M., Lee K.L., Bull D.A., et al. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 2011, 364(9):797-805.
35. Konstam M.A., Gheorghiade M., Burnett J.C., et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA 2007, 297(12):1319-1331.
36. Peacock W.F., Hollander J.E., Diercks D.B., et al. Morphine and outcomes in acute decompensated heart failure: an ADHERE analysis. Emerg Med J 2008, 25:205.
37. Publication Committee for the VMAC I Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA 2002, 287:1531-1540.
38. Peacock W.F., Emerman C.L., Silver M.A., et al. Nesiritide added to standard care favorably reduces systolic blood pressure compared with standard care alone in patients with acute decompensated heart failure. Am J Emerg Med 2005, 157:327.
39. Sackner-Bernstein J.D., Kowalski M., Fox M., et al. Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials. JAMA 2005, 293(15):1900-1905.
40. Ezekowitz J.A., Hernandez A.F., O'Connor C.M., et al. Assessment of dyspnea in acute decompensated heart failure: insights from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) on the contributions of peak expiratory flow. JAm Coll Cardiol 2012, 59(16):1441-1448.
41. Peacock W.F., Holland R., Gyarmathy R., et al. Observation unit treatment of heart failure with nesiritide: results from the proaction trial. JEmerg Med 2005, 29(3):243-252.
42. Ezekowitz J.A., Hernandez A.F., Starling R.C., et al. Standardizing care for acute decompensated heart failure in a large megatrial: the approach for the Acute Studies of Clinical Effectiveness of Nesiritide in Subjects with Decompensated Heart Failure (ASCEND-HF). Am Heart J 2009, 157(2):219-228.
43. Metra M., Cotter G., Davison B.A., et al. Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes. JAm Coll Cardiol 2013, 61(2):196-206.
44. Teerlink J.R., Cotter G., Davison B.A., et al. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. Lancet 2013, 381(9860):29-39.
45. Flaherty J.D., Bax J.J., DeLuca L., et al. Acute heart failure syndromes in patients with coronary artery disease: early assessment and treatment. JAm Coll Cardiol 2009, 53:254.
46. Dickstein K., Cohen-Solal A., Filippatos G., et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008, 29:2388.
47. Annane D., Bellissant E., Pussard E., et al. Placebo-controlled, randomized, double-blind study of intravenous enalaprilat efficacy and safety in acute cardiogenic pulmonary edema. Circulation 1996, 94(6):1316-1324.
48. Vital F.M., Saconato H., Ladeira M.T., et al. Non-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary edema. Cochrane Database Syst Rev 2008, (3). CD005351.
49. Masip J., Betbese A.J., Paez J., et al. Non-invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary edema: a randomized trial. Lancet 2000, 356(9248):2126-2132.
50. Mak S., Azevedo E.R., Liu P.P., et al. Effect of hyperoxia on left ventricular function and filling pressures in patients with and without congestive heart failure. Chest 2001, 120(2):467-473.
51. Schrock J.W., Emerman C.L. Observation unit management of acute decompensated heart failure. Heart Fail Clin 2009, 5(1):85. vii.
52. Shah S.J., Gheorghiade M. Heart failure with preserved ejection fraction: treat now by treating comorbidities. JAMA 2008, 300:431.
53. Gheorghiade M., Pang P.S. Acute heart failure syndromes. JAm Coll Cardiol 2009, 53(7):557-573.
54. Gheorghiade M., Abraham W.T., Albert N.M., et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA 2006, 296(18):2217-2226.
55. Cotter G., Metra M., Milo-Cotter O., et al. Fluid overload in acute heart failure-re-distribution and other mechanisms beyond fluid accumulation. Eur J Heart Fail 2008, 10(2):165-169.
56. Cotter G., Felker G.M., Adams K.F., et al. The pathophysiology of acute heart failure-is it all about fluid accumulation?. Am Heart J 2008, 155(1):9-18.
57. Adams K.F., Fonarow G.C., Emerman C.L., et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2005, 149(2):209-216.
58. Gheorghiade M., Braunwald E. Aproposed model for initial assessment and management of acute heart failure syndromes. JAMA 2011, 305(16):1702-1703.
59. Smith W.R., Poses R.M., McClish D.K., et al. Prognostic judgments and triage decisions for patients with acute congestive heart failure. Chest 2002, 121(5):1610-1617.
60. Peacock W.F., Fonarow G.C., Ander D.S., et al. Society of Chest Pain Centers Recommendations for the evaluation and management of the observation stay acute heart failure patient: a report from the Society of Chest Pain Centers Acute Heart Failure Committee. Crit Pathw Cardiol 2008, 7(2):83-86.
61. Fonarow G.C., Adams K.F., Abraham W.T., et al. Riskstratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA 2005, 293(5):572-580.
62. Auble T.E., Hsieh M., Gardner W., et al. Aprediction rule to identify low-risk patients with heart failure. Acad Emerg Med 2005, 12(6):514-521.
63. Hsieh M., Auble T.E., Yealy D.M. Validation of the acute heart failure index. Ann Emerg Med 2008, 51(1):37-44.
64. Hernandez A.F., Greiner M.A., Fonarow G.C., et al. Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. JAMA 2010, 303(17):1716-1722.
65. Storrow A.B., Collins S.P., Lyons M.S., et al. Emergency department observation of heart failure: preliminary analysis of safety and cost. Congest Heart Fail 2005, 11(2):68-72.
66. Baugh C.W., Venkatesh A.K., Hilton J.A., et al. Making greater use of dedicated hospital observation units for many short-stay patients could save $3.1 billion a year. Health Aff (Millwood) 2012, 31(10):2314-2323.
67. Gheorghiade M., De Luca L., Fonarow G.C., et al. Pathophysiologic targets in the early phase of acute heart failure syndromes. Am J Cardiol 2005, 96(6A):11G-17G.
68. Setoguchi S., Stevenson L.W., Schneeweiss S. Repeated hospitalizations predict mortality in the community population with heart failure. Am Heart J 2007, 154(2):260-266.
69. Graff L., Orledge J., Radford M.J., et al. Correlation ofthe Agency for Health Care Policy and Research congestive heart failure admission guideline with mortality: peer review organization voluntary hospital association initiative to decrease events (PROVIDE) for congestive heart failure. Ann Emerg Med 1999, 34(4 Pt 1):429-437.
70. Collins S.P., Pang P.S., Fonarow G.C., et al. Is hospital admission for heart failure really necessary?: the role of the emergency department and observation unit in preventing hospitalization and rehospitalization. JAm Coll Cardiol 2013, 61(2):121-126.
71. Peacock W.F., Fonarow G.C., Ander D.S., et al. Society of Chest Pain Centers recommendations for the evaluation and management of the observation stay acute heart failure patient-parts 1-6. Acute Card Care 2009, 11(1):3-42.